Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. Wanget al., Cell Mol. Neurobiol., 2016, 36:603-611; DOI 10.1007/s10571-015-0241-3 | ||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Kim et al., Mol. Cell Biol., 2015, 35:1754-1762; doi:10.1128/MCB.01325-14 | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | H. Guan et al., Experimental Neurology, 2017, 291: 51-61 | Link | |
SAS |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Xu et al., Journal of Cellular Biochemistry, DOI 10.1002/jcb.26642 | |||
SAS |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Xu et al., PLoS ONE, 2015, 10(3):e0121439; doi:10.1371/journal.pone.0121439 | Link | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Clinical and Translational Medicine, 2014, 3:1, doi:10.1186/2001-1326-3-1 | Link | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Tufano et al., Front. Cell Dev. Biol., 2021, 9: 718947, doi: 10.3389/fcell.2021.718947 | Link | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2015, 28; 442-452; doi: 10.1111/pcmr.12378 | |||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | F. Albano et al., Biochimie, 2012, DOI: 10.1016/j.biochi.2012.12.012 | |||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Cell Death and Disease, 2013, 4: e578, doi:10.1038/cddis.2013.109 | Link | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2013, 26: 900–911, doi: 10.1111/pcmr.12144 | |||
RKO |
Human colon carcinoma cell line | ATCC CRL-2577 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | K2 Transfection System | publication | Y. Kuslansky et al., Journal of General Virology, 2016, 97: 3313-3330, DOI 10.1099/jgv.0.000624 | Link | |
RKO |
Human colon carcinoma cell line | ATCC CRL-2577 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | N. Di Maio et al., FEBS Open Bio, 2017, 7: 1453-1468, doi:10.1002/2211-5463.12307 | Link | |
RKO |
Human colon carcinoma cell line | ATCC CRL-2577 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Alagoz et al., Nucleic Acids Res., Mar 2014; 42: 3089 - 3103 | Link | |
PM-WK |
Human skin malignant melanoma cell line | ATCC CRL-2624 | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Renziehausen et al., Oncogene, 2019, 38:2320–2336, doi.org/10.1038/s41388-018-0563-y | ||
Phoenix |
Retrovirus producer cell line (Derivat of 293T) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | E. Bernardinelli et al., PLOSONE, doi.org/10.1371/journal.pone.0179591 | Link | ||
Phoenix |
Retrovirus producer cell line (Derivat of 293T) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. Dossena et al., J. Biol. Chem., Nov 2011; 286: 40659 - 40670 | Link | ||
pHDF |
Human primary dermal fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Pesarchuk, 2016, Dissertation, Universtity of Vancouver | Link | ||
pHDF |
Human primary dermal fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | E. A. Ostrakhovitch et al., PLoS ONE, 2020, 15(11): e0241685, doi.org/10.1371/journal.pone.0241685 | Link | ||
pHDF |
Human primary dermal fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | E. A. Ostrakhovitch et al., Exp. Cell Res., 2019, 385: 111683, doi.org/10.1016/j.yexcr.2019.111683 | Link | ||
pHDF |
Human primary dermal fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
PC-3M |
Human prostate carcinoma cell line | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. L. Omara-Opyene et al., Lab Invest., 2004 Jul; 84(7):894-907 | |||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | U. Weirauch et al., Nucleic Acid Therapeutics, 2013, 23 (4): 264-272, DOI: 10.1089/nat.2012.0407 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | U. K. Mukhopadhyay et al., Cancer Res., Apr 2005; 65: 2872 - 2881 | Link |